**Core Concept**
TB treatment involves a combination of isoniazid, rifampicin, pyrazinamide, and ethambutol for the initial phase, which is usually continued for 2 months (Category I). The continuation phase involves isoniazid and rifampicin for 4 months (Category II) or 6 months in case of drug-resistant TB, with the aim of preventing relapse and reducing the risk of developing drug resistance.

**Why the Correct Answer is Right**
During domiciliary treatment, a person with tuberculosis is expected to take their medication regularly, maintain a healthy diet, and get adequate rest to promote healing and prevent complications. This includes attending regular follow-up appointments with their healthcare provider to monitor treatment progress and adjust the regimen as needed. The patient is also expected to inform their healthcare provider about any adverse effects or concerns they may have about their medication.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not necessarily incorrect, as patients on domiciliary treatment may be advised to avoid close contact with others to prevent transmission of the infection.

**Option B:** This option is incorrect, as patients on domiciliary treatment are not expected to stop taking their medication abruptly, as this can lead to treatment failure and the development of drug resistance.

**Option C:** This option is incorrect, as patients on domiciliary treatment may be advised to avoid close contact with others to prevent transmission of the infection, but they are not expected to completely isolate themselves.

**Clinical Pearl / High-Yield Fact**
It's essential for patients on domiciliary treatment to inform their healthcare provider about any adverse effects or concerns they may have about their medication, as this can help to prevent treatment failure and the development of drug resistance.

**Correct Answer:** B.